SICANDRA MEDICAL: what changed
SICANDRA MEDICAL
Largest movements
- Receivables within one year +€108,927
up €108,927 (+146%), from €74,737 to €183,664
of which Other amounts receivable: +€104,543
- Receivables after one year -€60,000
no longer reported in 2025 (was €60,000)
- Cash +€21,258
up €21,258 (+12.7%), from €167,610 to €188,869
mainly Net result for the year (+€67,990) and Receivables after one year (+€60,000)
- Deferred charges and accrued income +€5,149
up €5,149 (+129%), from €3,998 to €9,147
- Reserves +€33,683
up €33,683 (+14.3%), from €235,513 to €269,196
of which Distributable reserves: +€33,683
- Tax, wage and social debts +€22,068
up €22,068 (+444%), from €4,970 to €27,038
- Other debts +€21,302
up €21,302 (+339%), from €6,287 to €27,590
- Trade debts -€8,658
down €8,658 (-95.7%), from €9,049 to €392
- Advances received +€5,472
new in 2025: €5,472
- Gross operating margin +€9,280
up €9,280 (+9.2%), from €100,503 to €109,782
- Taxes +€8,160
up €8,160 (+27.5%), from €29,725 to €37,885
- Other operating charges +€4,215
up €4,215 (+2,139%), from €197 to €4,412
- Financial income +€1,886
up €1,886 (+32.9%), from €5,726 to €7,612
- Depreciation +€1,171
up €1,171 (+20.6%), from €5,673 to €6,844
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €325,820 | €399,688 | +€73,868 | +22.7% |
| Fixed assets | 21/28 | €19,474 | €18,008 | -€1,466 | -7.5% |
| Tangible fixed assets | 22/27 | €19,474 | €18,008 | -€1,466 | -7.5% |
| Plant, machinery and equipment | 23 | €4,679 | €4,278 | -€401 | -8.6% |
| Furniture and vehicles | 24 | €2,143 | €3,718 | +€1,575 | +73.5% |
| Other tangible fixed assets | 26 | €12,652 | €10,012 | -€2,640 | -20.9% |
| Current assets | 29/58 | €306,345 | €381,680 | +€75,335 | +24.6% |
| Amounts receivable after more than one year | 29 | €60,000 | - | -€60,000 | |
| Other amounts receivable | 291 | €60,000 | - | -€60,000 | |
| Amounts receivable within one year | 40/41 | €74,737 | €183,664 | +€108,927 | +146% |
| Trade receivables | 40 | €366 | €4,750 | +€4,385 | +1,200% |
| Other amounts receivable | 41 | €74,371 | €178,914 | +€104,543 | +141% |
| Cash at bank and in hand | 54/58 | €167,610 | €188,869 | +€21,258 | +12.7% |
| Deferred charges and accrued income | 490/1 | €3,998 | €9,147 | +€5,149 | +129% |
| Total equity and liabilities | 10/49 | €325,820 | €399,688 | +€73,868 | +22.7% |
| Equity | 10/15 | €305,513 | €339,196 | +€33,683 | +11.0% |
| Contributions | 10/11 | €70,000 | €70,000 | = | 0.0% |
| Reserves | 13 | €235,513 | €269,196 | +€33,683 | +14.3% |
| Tax-exempt reserves | 132 | €6,341 | €6,341 | = | 0.0% |
| Distributable reserves | 133 | €229,172 | €262,855 | +€33,683 | +14.7% |
| Amounts payable | 17/49 | €20,307 | €60,492 | +€40,185 | +198% |
| Amounts payable within one year | 42/48 | €20,307 | €60,492 | +€40,185 | +198% |
| Trade debts | 44 | €9,049 | €392 | -€8,658 | -95.7% |
| Suppliers | 440/4 | €9,049 | €392 | -€8,658 | -95.7% |
| Advances received on contracts in progress | 46 | - | €5,472 | +€5,472 | |
| Taxes, remuneration and social security | 45 | €4,970 | €27,038 | +€22,068 | +444% |
| Taxes | 450/3 | €4,970 | €27,038 | +€22,068 | +444% |
| Other amounts payable | 47/48 | €6,287 | €27,590 | +€21,302 | +339% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,673 | €6,844 | +€1,171 | +20.6% |
| Other operating charges | 640/8 | €197 | €4,412 | +€4,215 | +2,139% |
| Non-recurring operating charges | 66A | €1,161 | - | -€1,161 | |
| Gross operating margin | 9900 | €100,503 | €109,782 | +€9,280 | +9.2% |
| Operating profit (loss) | 9901 | €93,472 | €98,527 | +€5,055 | +5.4% |
| Financial income | 75/76B | €5,726 | €7,612 | +€1,886 | +32.9% |
| Recurring financial income | 75 | €5,726 | €7,612 | +€1,886 | +32.9% |
| Financial charges | 65/66B | €479 | €264 | -€215 | -44.8% |
| Recurring financial charges | 65 | €479 | €264 | -€215 | -44.8% |
| Profit (loss) for the period before taxes | 9903 | €98,719 | €105,875 | +€7,156 | +7.2% |
| Income taxes | 67/77 | €29,725 | €37,885 | +€8,160 | +27.5% |
| Profit (loss) for the period | 9904 | €68,995 | €67,990 | -€1,005 | -1.5% |
| Profit (loss) for the period to be appropriated | 9905 | €68,995 | €67,990 | -€1,005 | -1.5% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.